APLUSA is a global company specializing in real-world patient databases, with a particular focus on hematology, covering a remarkable 70% of all hematologic malignancies, including ALL, AML, CAR-T Therapy patients, CLL, CMV, DLBCL, Follicular Lymphoma, MDS, MM, Myelofibrosis, MZL, WM, Beta-Thalassemia, Hemophilia, ITP, PNH.